A Perry Karsen
Affiliations
- Director at Graphite Bio Inc. (GRPH), 2023-07-21
- Director at Jounce Therapeutics Inc. (JNCE), 2023-05-04
- Director at Intellia Therapeutics Inc. (NTLA), 2020-12-18
- Director at Jiya Acquisition Corp. (JYAC), 2020-11-19
- Director at Voyager Therapeutics Inc. (VYGR), 2019-06-17
- Director at Oncomed Pharmaceuticals Inc (OMED), 2019-04-23
- See Remarks at Celgene Corp (CELG), 2016-02-02
- Director at Navidea Biopharmaceuticals Inc. (NAVB), 2015-07-21
- Director at Agios Pharmaceuticals Inc (AGIO), 2015-06-25
- Director at Alliqua Inc. (ALQA), 2013-12-05
- President at Stalar 3 Inc. (NONE), 2011-01-24
- President at Stalar 4 Inc. (NONE), 2011-01-21
Insider Trading: Purchases See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
OMED | $3.46 | 10,000 | $34,588.00 | 10,000 | 2017-06-05 | Filing |
JNCE | $16.00 | 5,000 | $80,000.00 | 5,000 | 2017-02-01 | Filing |
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
NTLA | $54.33 | 21,336 | $1,159,184.88 | 5,000 | 2020-12-17 | Filing |
NTLA | $53.69 | 45,450 | $2,440,210.50 | 26,336 | 2020-12-17 | Filing |
NTLA | $52.52 | 21,978 | $1,154,284.56 | 71,786 | 2020-12-17 | Filing |
CELG | $115.00 | 47,173 | $5,424,895.00 | 62,820 | 2013-05-13 | Filing |
CELG | $120.12 | 27,896 | $3,350,728.04 | 70,117 | 2015-02-11 | Filing |